Lars Franzén - Concepedia

Author

Lars Franzén

Also Known As

Franzen, Louise Delwen Owen, L FRANZEN, L Franzen, L Franzén, L. FRANZÉN, L. Franzen, L. Franzèn, L. Franzén, Lars Franzen, Lars Franzén

125

Publications

7.8K

Citations

H-Index

Concepts

All Affiliations

Umeå University Lund University Karlstad Central Hospital Sahlgrenska University Hospital Skåne University Hospital

About

Lars Franzén is an author at Umeå University specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	41	3.5K
2	Health Sciences	18	22	2.1K
3	Public Health	2	2	150
4	Engineering	1	1	27
5	Social Sciences	1	1	79

Lars Franzén

Publications

7.4K

Citations

H-Index

Page 1

	Year	Citations
Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer Chris Parker, Sten Nilsson, Daniel Heinrich, New England Journal of Medicine	2013	3.3K
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial Anders Widmark, Adalsteinn Gunnlaugsson, L. Beckman, The Lancet Surgical OncologyRadiation TherapyMedicineProstatic DiseaseOncology	2019	840
Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study Sten Nilsson, Lars Franzén, Christopher Parker, The Lancet Oncology Bone-targeted Radium-223UrologyGenitourinary CancerMedicineCancer Treatment	2007	491
Parotid gland function during and following radiotherapy of malignancies in the head and neck Lars Franzén, Ulrika Funegård, T. Ericson, European Journal of Cancer Neuro-oncologyRadiation TherapyMedicinePathologyRadiopharmaceutical Therapy	1992	245
Boron neutron capture therapy (BNCT) for glioblastoma multiforme: A phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA) Roger Henriksson, Jacek Capala, Annika Michanek, Radiotherapy and Oncology Prolonged High-doseGliomaRadiation TherapyGlioblastoma MultiformeMedicine	2008	157
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial Per Fransson, Per Nilsson, Adalsteinn Gunnlaugsson, The Lancet Oncology Radiation MedicineRadiation TherapyMedicineProstatic DiseaseOncology	2021	151
Boron Neutron Capture Therapy for Glioblastoma Multiforme: Clinical Studies in Sweden Jacek Capala, Britta Stenstam, K. Sköld, Journal of Neuro-Oncology Neuro-oncologyGliomaGlioblastoma MultiformeMedicineClinical Studies	2003	141
Effects of sucralfate on acute and late bowel discomfort following radiotherapy of pelvic cancer. Roger Henriksson, Lars Franzén, B. Littbrand Journal of Clinical Oncology	1992	125
Two-Year Survival Follow-Up of the Randomized, Double-Blind, Placebo-Controlled Phase II Study of Radium-223 Chloride in Patients With Castration-Resistant Prostate Cancer and Bone Metastases Sten Nilsson, Lars Franzén, Christopher Parker, Clinical Genitourinary Cancer UrologySurgical OncologyGenitourinary CancerMedicineTwo-year Survival Follow-up	2012	118
Boron neutron capture therapy for glioblastoma multiforme: clinical studies in Sweden Jacek Capala, Britta Stenstam, K. Sköld, Journal of Neuro-Oncology Neuro-oncologyGliomaGlioblastoma MultiformeMedicineClinical Studies	2003	115

Page 1